Clinical Trial Update: An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

View source ↗

Summary

This is an observational real-world study to assess changes in disease activity and adverse events in adults with moderate to severe ulcerative colitis treated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis | Status: ACTIVE_NOT_RECRUITING